Clinical Study

Assessing the Discriminative Ability and Internal Consistency of the School Outcomes Measure

Table 2

Primary diagnosis of student participants ( ) (number (%)).

ā€‰Total
( )
Mild/moderate disability
( )
Severe disability
( )

Cerebral palsy22 (30.1)4 (10.2)18 (52.9)
Developmental delay8 (10.9)6 (15.3)2 (05.8)
Autism spectrum disorder6 (08.2)6 (15.3)0 (0.0)
Down syndrome5 (06.8)4 (10.2)1 (02.9)
Traumatic brain injury3 (04.1)3 (07.7)0 (0.0)
Brain tumor2 (02.7)1 (02.5)1 (02.9)
Hydrocephalus2 (02.7)0 (0.0)2 (05.8)
Anoxia1 (01.3)1 (02.5)0 (0.0)
ADHD1 (01.3)1 (02.5)0 (0.0)
CVA1 (01.3)1 (02.5)0 (0.0)
DiGeorge syndrome1 (01.3)1 (02.5)0 (0.0)
Failure to thrive1 (01.3)0 (0.0)1 (02.9)
Fetal alcohol syndrome1 (01.3)1 (02.5)0 (0.0)
Lawrence-Moon1 (01.3)1 (02.5)0 (0.0)
Learning disability1 (01.3)1 (02.5)0 (0.0)
Muscular dystrophy1 (01.3)0 (0.0)1 (02.9)
Mental retardation/cerebral palsy1 (01.3)0 (0.0)1 (02.9)
Shaken baby syndrome1 (01.3)0 (0.0)1 (02.9)
Rhett syndrome1 (01.3)0 (0.0)1 (02.9)
Spina bifida1 (01.3)0 (0.0)1 (02.9)
Sturge-Weber syndrome1 (01.3)1 (02.5)0 (0.0)
Not identified11 (15.0)7 (17.9)4 (11.7)